RET and neuroblastoma: As shown in Figure 2A, we found that regorafenib diminished the phosphorylation of p-RET (Y1062) and inhibited the downstream phosphorylation of p-AKT (S473) and p-S6 (S235/236) in all of the three NB cell lines tested (Figure 2A).